Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yueyu Cao

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Oncotarget|March 23, 2016
Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLCYueyu Cao, Mengdan Wei, Bing Li, et al.
Blood|November 5, 2015
Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphomaLu Dai, Jimena Trillo-Tinoco, Yueyu Cao, et al.
Cancer Discovery|June 8, 2021
MET Amplification Attenuates Lung Tumor Response to Immunotherapy by Inhibiting STINGYong Zhang, Qifan Yang, Xiangyu Zeng, et al.
Nature Cancer|September 22, 2022
METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinomaXiangyu Zeng, Fei Zhao, Gaofeng Cui, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Oncotarget|March 23, 2016
Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLCYueyu Cao, Mengdan Wei, Bing Li, et al.
Blood|November 5, 2015
Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphomaLu Dai, Jimena Trillo-Tinoco, Yueyu Cao, et al.
Cancer Discovery|June 8, 2021
MET Amplification Attenuates Lung Tumor Response to Immunotherapy by Inhibiting STINGYong Zhang, Qifan Yang, Xiangyu Zeng, et al.
Nature Cancer|September 22, 2022
METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinomaXiangyu Zeng, Fei Zhao, Gaofeng Cui, et al.
Pageof 2